[Interstial pneumonia, which activity was reflected on KL-6, associated with dermatomyositis successfully treated with cyclosporin A].
Niinaka
Manabu
M
Department of Internal Medicine, Hyogo College of Medicine.
Matsui
Kiyoshi
K
Aizawa
Nobuhiro
N
Tominaga
Kouji
K
Iida
Shinichiro
S
Nakano
Takashi
T
Hada
Toshikazu
T
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D000941:Antigens / Q000097:blood*; D000951:Antigens, Neoplasm; D015415:Biomarkers / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D003882:Dermatomyositis / Q000188:drug therapy*; D004351:Drug Resistance; D005260:Female; D006023:Glycoproteins / Q000097:blood*; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000150:complications* / Q000188:drug therapy; D008875:Middle Aged; D018396:Mucin-1; D009077:Mucins; D011239:Prednisolone / Q000008:administration & dosage; D020551:Pulse Therapy, Drug
D000893:Anti-Inflammatory Agents; D000941:Antigens; D000951:Antigens, Neoplasm; D015415:Biomarkers; D003879:Dermatologic Agents; D006023:Glycoproteins; C060192:MUC1 protein, human; D018396:Mucin-1; D009077:Mucins; D016572:Cyclosporine; D011239:Prednisolone